Showing 2,881 - 2,900 results of 24,535 for search 'LiveAD~', query time: 5.16s Refine Results
  1. 2881

    Frequency Of Prolonged Qtc in Patients With Decompensated Chronic Liver Disease In A Rural Cohort Of Sindh by Adeel Ahmed, Bushra Rabbani, Muhammad Kamran, Ammarah Saeed, Jameel Ahmed

    Published 2024-06-01
    “…With decompensated chronic liver disease (DCLD) in a tertiary care hospital of Gadap town, Sindh. …”
    Get full text
    Article
  2. 2882

    Identification of CD8+ T Cell-Related Genes: Correlations with Immune Phenotypes and Outcomes of Liver Cancer by Qi Pan, Ying Cheng, Donghua Cheng

    Published 2021-01-01
    “…Treatment outcomes for advanced liver cancer are poor. Immunotherapy is a treatment strategy that has been widely used to treat other cancers. …”
    Get full text
    Article
  3. 2883
  4. 2884
  5. 2885

    Donor Small-Droplet Macrovesicular Steatosis Affects Liver Transplant Outcome in HCV-Negative Recipients by Flaminia Ferri, Quirino Lai, Antonio Molinaro, Edoardo Poli, Lucia Parlati, Barbara Lattanzi, Gianluca Mennini, Fabio Melandro, Francesco Pugliese, Federica Maldarelli, Alessandro Corsi, Mara Riminucci, Manuela Merli, Massimo Rossi, Stefano Ginanni Corradini

    Published 2019-01-01
    “…No data are available on liver transplantation (LT) outcome and donor liver steatosis, classified as large droplet macrovesicular (Ld-MaS), small-droplet macrovesicular (Sd-MaS), and true microvesicular (MiS), taking into account the recipient Hepatitis C virus (HCV) status. …”
    Get full text
    Article
  6. 2886

    Putative Factors That May Modulate the Effect of Exercise on Liver Fat: Insights from Animal Studies by Faidon Magkos

    Published 2012-01-01
    “…An increase in intrahepatic triglyceride (IHTG) content is the hallmark of nonalcoholic fatty liver disease (NAFLD) and is strongly associated with insulin resistance and dyslipidemia. …”
    Get full text
    Article
  7. 2887
  8. 2888

    Infrahepatic Inferior Vena Cava Clamping Reduces Blood Loss during Liver Transection for Cholangiocarcinoma by Natwutpong Leeratanakachorn, Vor Luvira, Theerawee Tipwaratorn, Suapa Theeragul, Apiwat Jarearnrat, Attapol Titapun, Tharatip Srisuk, Supot Kamsa-ard, Ake Pugkhem, Narong Khuntikeo, Chawalit Pairojkul, Vajarabhongsa Bhudhisawasdi

    Published 2021-01-01
    “…Infrahepatic inferior vena cava (IVC) clamping is an effective maneuver for reducing blood loss during liver transection. The impact of this procedure on major hepatectomy for cholangiocarcinoma is unknown. …”
    Get full text
    Article
  9. 2889

    Ascorbic acid-immobilized zinc selenide for electrochemical monitoring of hydrogen peroxide in liver cancer samples by Shan E Zahra Jawad, Sibtain Ahmed, Dilshad Hussain, Javerya Najeeb, Ayub Alam, Muhammad Najam-ul-Haq, Batool Fatima

    Published 2025-01-01
    “…Abstract Liver cancer is globally the most frequent fatal malignancy, and its identification is critical for making clinical decisions about treatment options. …”
    Get full text
    Article
  10. 2890

    Relevance of 3D Cholangiography and Transient Elastography to Assess Cystic Fibrosis-Associated Liver Disease? by C. Lemaitre, S. Dominique, E. Billoud, M. Eliezer, H. Montialoux, M. Quillard, G. Riachi, E. Koning, H. Morisse-Pradier, G. Savoye, C. Savoye-Collet, O. Goria

    Published 2016-01-01
    “…Cystic fibrosis-associated liver disease (CFLD) is a major cause of death. The objective of our retrospective study was to describe the relevance of magnetic resonance imaging (MRI) and liver stiffness measurement (LSM) for CFLD evaluation. …”
    Get full text
    Article
  11. 2891

    Diet quality and physical activity affect metabolic dysfunction-associated steatotic liver disease, metabolic dysfunction and etiology-associated steatohepatitis, and compensated advanced chronic liver disease among United States adults: NHANES 2017–2020 by Peng Wang, Bingxin Xia, Shuang Wang

    Published 2025-01-01
    “…Background and aimClinical data on the prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction and etiology-associated steatohepatitis (MetALD) in a multi-ethnic U.S. population are limited. …”
    Get full text
    Article
  12. 2892
  13. 2893
  14. 2894
  15. 2895
  16. 2896
  17. 2897
  18. 2898
  19. 2899
  20. 2900